Objective: To describe the aspects with the greatest impact on the satisfaction of patients treated in a multidisciplinary unit specialising in immune-mediated inflammatory diseases (IMIDs) and to identify areas for improvement in the care model.
Methods: Cross-sectional descriptive study using a satisfaction survey structured in three blocks: sociodemographic variables, functional aspects of the unit and satisfaction with the professionals. Immediate satisfaction was measured on aspects related to the care received, the physical structure and the likelihood of recommending the unit.
Background: Prediction of the response to a biological treatment in psoriasis patients would allow efficient treatment allocation.
Objective: To identify polymorphisms associated with secukinumab response in psoriasis patients in a daily practice setting.
Methods: We studied 180 SNPs in patients with moderate-to-severe plaque psoriasis recruited from 15 Spanish hospitals.
Background: Safety is an important consideration in decisions on treatment for patients with moderate-to-severe psoriasis and the study of drug safety is the main purpose of the BIOBADADERM registry. The combination of a biologic agent and a conventional systemic drug [generally methotrexate (MTX)] is a common treatment in clinical practice. However, there is a paucity of evidence from real-world practice on the safety of such combination regimens in the treatment of psoriasis.
View Article and Find Full Text PDFBackground And Objective: A significant proportion of women of childbearing age have psoriasis. The aim of this study was to examine family planning concerns in this population.
Material And Methods: Observational, descriptive, cross-sectional, multicenter study conducted between March 2020 and October 2021.